JESSICA BACHE: Open Payments
NPI 1801373493 · MILLEDGEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,310 in 95 payments from 35 companies in 2025. Trend: 2023 $168 · 2024 $1,023 · 2025 $2,310
Food & beverage: $2,215Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $281 |
| Novartis Pharmaceuticals Corporation | 6 | $159 |
| Daiichi Sankyo Inc. | 6 | $143 |
| Incyte Corporation | 5 | $127 |
| Janssen Biotech, Inc. | 5 | $121 |
| Exelixis Inc. | 2 | $117 |
| Merck Sharp & Dohme LLC | 5 | $113 |
| Genentech USA, Inc. | 5 | $102 |
| GlaxoSmithKline, LLC. | 5 | $99 |
| ABBVIE INC. | 4 | $88 |
Products named: Enhertu, KISQALI, KEYTRUDA, TECVAYLI, TEVIMBRA, ZEPZELCA, JAKAFI, LYNPARZA.
Industry payments across GA — which companies pay providers there.
